Beste Neuroscience Research Podcasts (2025)

1
31: Podcast Updates with Marie McNeely 1:13

3M ago1:13

1:13

In this short episode, host Dr. Marie McNeely shares updates about the podcast and provides listeners with more information on how they can stay connected with MJFF for future podcast episodes as The Parkinson’s Research Podcast merges with The Michael J. Fox Foundation Parkinson’s Podcast. Visit https://www.michaeljfox.org/podcasts for more great …

1
30: The Role of Diet and Nutrition in Parkinson’s Disease and Brain Health with Puja Agarwal 42:25

3M ago42:25

42:25

It is widely known that a healthy diet can provide essential nutrients and lead to a multitude of benefits, but growing evidence has highlighted important links between diet, nutrition, and brain health, particularly related to neurodegenerative disease. In this episode, Dr. Puja Agarwal discusses her research investigating the role that diet and n…

1
29: Developing a Novel App to Improve Speech Intelligibility in Parkinson's Disease with Gemma Moya-Galé 43:47

3M ago43:47

43:47

Parkinson's disease significantly impacts various aspects of communication, and this can make it challenging for people with the disease to communicate effectively, be understood by others, and engage in social situations. Dr. Gemma Moya-Galé joins this episode to talk about her work on voice and communication in people with Parkinson’s disease. In…

1
28: Increasing Diversity in Research and Addressing Brain Health Inequities with Monica Rivera-Mindt 44:05

4M ago44:05

44:05

Certain populations are disproportionately affected by neurological diseases, including Parkinson's and other neurodegenerative diseases. A lot of work remains to be done to improve brain health outcomes and promote healthy brain aging across the lifespan, particularly for minoritized, underrepresented populations. Including participants from diver…

1
27: The Development and Application of the Alpha-Synuclein Seed Amplification Assay with Claudio Soto 37:27

4M ago37:27

37:27

Alpha-synuclein plays a key role in the pathophysiology of Parkinson's disease, and researchers have been investigating this protein as a therapeutic target and also as a potential biomarker for the disease. The alpha-synuclein seed amplification assay, developed by Dr. Claudio Soto and colleagues, leverages the self-replicating nature of the misfo…

1
26: An Inside Look at the Edmond J. Safra Fellowship in Movement Disorders with Marcelo Merello and Sergio Castillo-Torres 57:54

5M ago57:54

57:54

To help meet the growing global need for more movement disorders specialists, The Michael J. Fox Foundation created the Edmond J. Safra Fellowship in Movement Disorders in collaboration with longtime partner the Edmond J. Safra Foundation. This program supports the training of movement disorders specialists who will provide expert care and drive ad…

1
25: Creating Alpha-Synuclein Cell Lines and Supporting Open Science with Birgitt Schüle 36:42

5M ago36:42

36:42

Stem cell models derived from patients with Parkinson’s disease are valuable tools that are helping researchers around the world to better understand the underlying causes of neurodegeneration and to develop biomarkers and new therapies. To maximize the potential impacts of these tools, it is critical that they are developed and shared according to…

1
24: Developing FLEXISyn to Identify and Measure Changes in Alpha-Synuclein in Parkinson's Disease with Judith Steen 35:48

6M ago35:48

35:48

New qualitative and quantitative tools are being developed to measure and track changes in proteins relevant for neurodegenerative disease, and these tools have the potential to accelerate drug discovery and clinical trials. In this episode, Dr. Judith Steen discusses her work creating novel qualitative and quantitative tools and workflows at the i…

1
23: Clinical Applications of Biomarkers and Large-Scale Collaborative Research with Charles Adler 45:52

6M ago45:52

45:52

Substantial research has focused on identifying biomarkers for the diagnosis of Parkinson's disease (PD) as well as monitoring progression of the disease. In developing these biomarkers, it is critical for scientists to consider how the biomarkers will ultimately be used in the clinic and in clinical trials research. In this interview, Dr. Charles …

1
22: Investigating Light Therapy For Sleep and Motor Function in People with PD with Beatrix Feigl 41:20

7M ago41:20

41:20

Sleep disturbances, such as insomnia, sleep fragmentation, excessive daytime sleepiness, and REM sleep behavior disorder are common in people with Parkinson's disease (PD). Poor sleep quality can also impact other domains of function, including motor function. Prior research has shown that a type of photoreceptor cell in the retina, called melanops…

1
21: The Autophagy-Lysosomal Pathway and Development of Relevant PD Biomarkers with Zhenyu Yue 31:54

7M ago31:54

31:54

Though existing evidence supports that dysfunction in the clearing of cellular debris plays an important role in the development of Parkinson's disease, many unanswered questions remain regarding the mechanisms of the autophagy-lysosomal pathway involved in this process. In particular, research in the field has been limited by a lack of reliable, q…

1
20: Studying CSF Element Profiles and Tear Fluid as Potential Biomarkers, and Novel and Combined Therapies for PD with Paul Lingor 47:28

8M ago47:28

47:28

Evidence supports that dysfunction in the homeostasis of iron and other elements likely contributes to the pathophysiological mechanisms of Parkinson's disease, but we have yet to develop suitable elemental biomarkers for use in diagnosing and monitoring the progression of Parkinson's disease. Dr. Paul Lingor discusses his work in this area to iden…

1
19: Current and Emerging Imaging Biomarkers for Diagnosis and Prognosis of PD and Atypical Parkinsonism with Antonio Strafella 37:29

8M ago37:29

37:29

Identifying reliable biomarkers for the diagnosis and prognosis of Parkinson's disease and atypical parkinsonism would have substantial impacts on clinical trials and clinical practice. A particularly active area of research is the development of novel molecular imaging biomarkers that can be used in combination with common neuroimaging approaches.…

1
18: Examining Links Between Environmental Exposure, Poor Olfaction, and Parkinson's Disease with Honglei Chen 46:47

9M ago46:47

46:47

Prior studies have established links between poor olfaction and Parkinson's disease, and impaired sense of smell is a common prodromal symptom of Parkinson's disease. The causes and mechanisms of prodromal neurodegeneration are actively being researched. However, environmental exposure to pesticides or other chemicals may trigger or modify the cour…

1
17: Developing Interventions to Improve Gait and Increase Physical Activity in Parkinson’s Disease with Gammon Earhart 42:37

9M ago42:37

42:37

Gait impairments such as slow speed, small steps, and high variability from step to step are common in people with Parkinson's disease, and these changes begin to occur early in the course of disease. Freezing of gait may develop later for some individuals, and it has been linked to falls and other adverse outcomes. When the quality of walking decl…

1
16: Studying Basal Ganglia Circuits and Developing Deep Brain Stimulation Protocols for Longer-Lasting Effects with Aryn Gittis 44:21

10M ago44:21

44:21

Improving our understanding of the complex neural circuits involved in normal function of the basal ganglia and other parts of the brain impacted by Parkinson's disease is critical for developing more targeted and more effective treatment approaches. In this episode, Dr. Aryn Gittis discusses her research examining how the activity of specific basa…

1
15: Innovative Fellowship Program is Training Tomorrow's Parkinson's Leaders with Rachel Dolhun 40:10

10M ago40:10

40:10

Demand for movement disorder specialists continues to grow, but not enough neurologists are receiving focused training in Parkinson’s and related conditions in order to meet the current and projected needs in the U.S. and around the world. In collaboration with longtime partner the Edmond J. Safra Foundation, The Michael J. Fox Foundation created t…

1
14: Evidence Linking Parkinson's Disease Risk and Environmental Exposure to Trichloroethylene (TCE) with Sam Goldman 39:22

11M ago39:22

39:22

Trichloroethylene (TCE) and related chemicals like perchloroethylene (PCE) have been used widely for a variety of commercial purposes over the past century, and these chemicals are prevalent in the air, water, and soil. Over the past several decades, mounting evidence has been published linking exposure to TCE/PCE with adverse health effects, inclu…

1
13: New Advances in Neurosurgical Interventions for Parkinson's Disease with Doris Wang 40:27

12M ago40:27

40:27

For over a century, different surgical interventions have been explored to address symptoms of Parkinson's disease, and researchers are continuing to innovate and improve surgical treatments today. With new technology and an ever-expanding understanding of the function of the nervous system and the pathophysiology of Parkinson's disease, neurosurgi…

1
12: Accelerating Discovery by Developing and Distributing Research Tools with Nicole Polinski 33:42

12M ago33:42

33:42

The Michael J. Fox Foundation for Parkinson's Research established its Research Tools Program to address gaps in the field and common challenges surrounding the development of reagents and models that slowed the initial stages of promising research projects. In collaboration with many partners and stakeholders, the Research Tools Program helps ensu…

1
11: The Importance of Sex and Gender Factors in Neurodegenerative Disease Research and Care with Antonella Santuccione Chadha 46:33

1y ago46:33

46:33

Increasing evidence supports the presence of sex and gender differences in neurodegenerative conditions, including Alzheimer's disease and Parkinson's disease. There is a critical need to more closely examine sex and gender differences in all stages of research, therapeutic development, and clinical treatment to enable better outcomes through preci…

1
10: Understanding Genetics, Pathology, and Progression in Parkinson's Disease and Atypical Parkinsonian Syndromes with Huw Morris 43:54

1y ago43:54

43:54

Atypical Parkinsonian Syndromes, such as progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and dementia with Lewy bodies are often initially diagnosed as Parkinson's disease. Incorrect, incomplete, or delayed diagnoses are barriers to beginning the most appropriate treatment early in the disease c…

1
9: Examining the Proposed Biological Definition of Neuronal Alpha-Synuclein Disease and Staging System with Lana Chahine 38:04

1y ago38:04

38:04

For many years, Parkinson's disease and dementia with Lewy bodies have been defined using clinical features. With recent advances in biomarkers, particularly the alpha-synuclein seed amplification assay that allows us to detect misfolded and aggregated alpha-synuclein in cerebrospinal fluid, it is now possible to identify the presence of pathologic…

1
8: Managing Risk for Drug Discovery and Development in Parkinson's Disease with Kalpana Merchant 1:07:19

1y ago1:07:19

1:07:19

There is a pressing need to develop safe and effective disease-modifying and symptomatic treatments for Parkinson's disease. Through improvements in our understanding of the pathophysiology of the disease, as well as genetic risk factors, new potential treatment targets have emerged. However, bringing a promising new compound from the lab through a…

1
7: Using Neuroimaging and Biomarkers to Improve Neurodegenerative Disease Diagnosis and Assessment with John Seibyl 52:41

1y ago52:41

52:41

In neurodegenerative conditions such as Parkinson's disease (PD), patients often do not receive a diagnosis until the hallmark motor symptoms begin to manifest. This can be a decade or more after substantial changes start occurring in the brain. A major goal of the PD research field has been to develop methods for earlier detection and intervention…

1
6: Impacts and Goals of the Global Parkinson's Genetics Program with Christine Klein 44:53

1y ago44:53

44:53

A substantial portion of people with Parkinson's disease (PD) have a family history of the disease, and new findings continue to improve our understanding of relevant genetic variants. These discoveries are key for clarifying the mechanisms that lead to Parkinson's disease as well as the development of new therapies. The Global Parkinson's Genetics…

1
5: The Role of Inflammation and Immune Responses in Neurodegeneration with Malú Gámez Tansey 51:37

1+ y ago51:37

51:37

A growing body of evidence is expanding our understanding of the links between inflammation, our immune responses, brain health, and neurodegeneration. In particular, several genes associated with Parkinson's (including LRRK2) are known to be involved in inflammation, and peripheral inflammation has been shown to influence brain function and contri…

1
4: Elucidating the Pathobiology of LRRK2 in Parkinson's Disease with Dario Alessi 48:16

1+ y ago48:16

48:16

Mutations in the LRRK2 gene were first linked to Parkinson's disease (PD) risk in 2004. Since then, researchers from around the world have advanced our understanding of the mechanisms through which LRRK2 may contribute to PD, leading to the development of three potential LRRK2-targeted therapies that are now being evaluated in clinical trials. Alon…

1
3: New Frontiers in Deep Brain Stimulation Research for Parkinson’s disease with Michael Okun 54:01

1+ y ago54:01

54:01

For decades, researchers, clinicians, and industry professionals have continued to study and optimize deep brain stimulation (DBS) with the goal of providing the best possible personalized treatment for Parkinson’s disease (PD) and other neurological conditions. In this episode, Dr. Michael Okun joins us to discuss his research and some of the rece…

1
2: Understanding Sleep Differences in Parkinson’s Disease with Dr. Amy Amara 28:55

1+ y ago28:55

28:55

Sleep impacts our lives in many different ways, and Dr. Amy Amara joins us in this episode to discuss her career and findings from her research on sleep in Parkinson’s disease (PD). She shares her insights on the characteristics of sleep in people with Parkinson’s disease, how sleep can be impacted by exercise, medications, and deep brain stimulati…

1
1: Industry Contributions and Collaborations in Parkinson's Research with Karoly Nikolich 42:04

1+ y ago42:04

42:04

In this episode, serial entrepreneur Dr. Karoly Nikolich shares his perspectives on the industry side of the state of neuroscience, as well as areas of opportunity and the role of industry in advancing the field. He also discusses recent major breakthroughs, the importance of industry partnerships, including collaborations with The Michael J. Fox F…

1
0: The Parkinson's Research Landscape and the Role of MJFF with Brian Fiske and Mark Frasier 36:56

1+ y ago36:56

36:56

New research advances are expanding our knowledge of Parkinson's disease and bringing us closer to the ultimate goals of new treatments, effective cures, and disease prevention. In this introductory episode, you'll hear from Dr. Brian Fiske and Dr. Mark Frasier, Co-Chief Scientific Officers at The Michael J. Fox Foundation for Parkinson's Research …

Podcasts, die es wert sind, gehört zu werden

Neuroscience Research Podcasts

Podcasts, die es wert sind, gehört zu werden

1
The Parkinson’s Research Podcast: New Discoveries in Neuroscience

The Michael J. Fox Foundation for Parkinson’s Research

1
31: Podcast Updates with Marie McNeely 1:13

1
30: The Role of Diet and Nutrition in Parkinson’s Disease and Brain Health with Puja Agarwal 42:25

1
29: Developing a Novel App to Improve Speech Intelligibility in Parkinson's Disease with Gemma Moya-Galé 43:47

1
28: Increasing Diversity in Research and Addressing Brain Health Inequities with Monica Rivera-Mindt 44:05

1
27: The Development and Application of the Alpha-Synuclein Seed Amplification Assay with Claudio Soto 37:27

1
26: An Inside Look at the Edmond J. Safra Fellowship in Movement Disorders with Marcelo Merello and Sergio Castillo-Torres 57:54

1
25: Creating Alpha-Synuclein Cell Lines and Supporting Open Science with Birgitt Schüle 36:42

1
24: Developing FLEXISyn to Identify and Measure Changes in Alpha-Synuclein in Parkinson's Disease with Judith Steen 35:48

1
23: Clinical Applications of Biomarkers and Large-Scale Collaborative Research with Charles Adler 45:52

1
22: Investigating Light Therapy For Sleep and Motor Function in People with PD with Beatrix Feigl 41:20

1
21: The Autophagy-Lysosomal Pathway and Development of Relevant PD Biomarkers with Zhenyu Yue 31:54

1
20: Studying CSF Element Profiles and Tear Fluid as Potential Biomarkers, and Novel and Combined Therapies for PD with Paul Lingor 47:28

1
19: Current and Emerging Imaging Biomarkers for Diagnosis and Prognosis of PD and Atypical Parkinsonism with Antonio Strafella 37:29

1
18: Examining Links Between Environmental Exposure, Poor Olfaction, and Parkinson's Disease with Honglei Chen 46:47

1
17: Developing Interventions to Improve Gait and Increase Physical Activity in Parkinson’s Disease with Gammon Earhart 42:37

1
16: Studying Basal Ganglia Circuits and Developing Deep Brain Stimulation Protocols for Longer-Lasting Effects with Aryn Gittis 44:21

1
15: Innovative Fellowship Program is Training Tomorrow's Parkinson's Leaders with Rachel Dolhun 40:10

1
14: Evidence Linking Parkinson's Disease Risk and Environmental Exposure to Trichloroethylene (TCE) with Sam Goldman 39:22

1
13: New Advances in Neurosurgical Interventions for Parkinson's Disease with Doris Wang 40:27

1
12: Accelerating Discovery by Developing and Distributing Research Tools with Nicole Polinski 33:42

1
11: The Importance of Sex and Gender Factors in Neurodegenerative Disease Research and Care with Antonella Santuccione Chadha 46:33

1
10: Understanding Genetics, Pathology, and Progression in Parkinson's Disease and Atypical Parkinsonian Syndromes with Huw Morris 43:54

1
9: Examining the Proposed Biological Definition of Neuronal Alpha-Synuclein Disease and Staging System with Lana Chahine 38:04

1
8: Managing Risk for Drug Discovery and Development in Parkinson's Disease with Kalpana Merchant 1:07:19

1
7: Using Neuroimaging and Biomarkers to Improve Neurodegenerative Disease Diagnosis and Assessment with John Seibyl 52:41

1
6: Impacts and Goals of the Global Parkinson's Genetics Program with Christine Klein 44:53

1
5: The Role of Inflammation and Immune Responses in Neurodegeneration with Malú Gámez Tansey 51:37

1
4: Elucidating the Pathobiology of LRRK2 in Parkinson's Disease with Dario Alessi 48:16

1
3: New Frontiers in Deep Brain Stimulation Research for Parkinson’s disease with Michael Okun 54:01

1
2: Understanding Sleep Differences in Parkinson’s Disease with Dr. Amy Amara 28:55

1
1: Industry Contributions and Collaborations in Parkinson's Research with Karoly Nikolich 42:04

1
0: The Parkinson's Research Landscape and the Role of MJFF with Brian Fiske and Mark Frasier 36:56

Kurzanleitung